Arrivano nelle farmacie e parafarmacie nuove specialità medicinali: Bitrapol, Dupixent e 11 nuovi farmaci equivalenti
Sono ora disponibili nelle farmacie e parafarmacie nuove specialità medicinali: Bitrapol, Dupixent e 11 nuovi farmaci equivalenti.
Nuove specialità medicinali
BITRAPOL collirio 30 contenitori monodose 0,4 ml 300 mcg/ml + 5 mg/ml timololo maleato/bimatoprost
GENETIC AIC:045921018 18,40€ A/RR in commercio dal:18/11/2024
DUPIXENT 2 penne preriempite SC 200 mg 1,14 ml dupilumab
SANOFI-AVENTIS AIC:045676246 2.006,88€ A/RRL in commercio dal:12/11/2024
DUPIXENT 2 penne preriempite SC 300 mg 2 ml dupilumab
SANOFI-AVENTIS AIC:045676273 2.006,88€ A/RRL in commercio dal:12/11/2024
Nuovi farmaci equivalenti
BEXAROTENE CIPLA 100 cps molli 75 mg flacone bexarotene
CIPLA EUROPE AIC:048410017 901,14€ A/RNRL in commercio dal:12/11/2024
EZETIMIBE E ATORVASTATINA EG STADA 30 cpr riv 10 mg + 10 mg ezetimibe/atorvastatina calcio triidrato
EG AIC:050978016 10,30€ A/RR in commercio dal:14/11/2024
METFORMINA EG STADA ITALIA 60 cpr riv 1.000 mg metformina cloridrato
EG AIC:049629102 3,64€ A/RR in commercio dal:14/11/2024
NAVERUCLIF 1 flaconcino EV 100 mg 20 ml 5 mg/ml paclitaxel
ACCORD AIC:051048015 332,24€ Cnn/OSP in commercio dal:14/11/2024
PIRFENIDONE ACCORD 84 cpr riv 801 mg pirfenidone
ACCORD AIC:050191143 2.521,48€ H/RNRL in commercio dal:18/11/2024
POMALIDOMIDE VIATRIS 21 cps 1 mg pomalidomide
VIATRIS AIC:051116034 9.780,88€ H/RNRL in commercio dal:15/11/2024
POMALIDOMIDE VIATRIS 21 cps 3 mg pomalidomide
VIATRIS AIC:051116111 9.780,88€ H/RNRL in commercio dal:15/11/2024
POMALIDOMIDE VIATRIS 21 cps 4 mg pomalidomide
VIATRIS AIC:051116150 9.780,88€ H/RNRL in commercio dal:16/11/2024
TELMISARTAN AUROBINDO 28 cpr 20 mg telmisartan
AUROBINDO AIC:049831011 3,80€ A/RR in commercio dal:15/11/2024
TELMISARTAN AUROBINDO 28 cpr 40 mg telmisartan
AUROBINDO AIC:049831023 4,00€ A/RR in commercio dal:15/11/2024
TELMISARTAN AUROBINDO 28 cpr 80 mg telmisartan
AUROBINDO AIC:049831035 5,50€ A/RR in commercio dal:15/11/2024